Crystal Field Theory - Octahedral Complexes
Ligand Binding Sites
Positive Regulator Molecules
Inhibition of Cdk Activity
Ligand Binding Sites
Inhibition of CDK Activity
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Yongjun Jiang1, Jianwei Zou, Chunshan Gui
1Key Laboratory for Molecular Design and Nutrition Engineering, Ningbo Institute of Technology, Zhejiang University, Ningbo, 315104, P.R. China. yjjiang@nit.net.cn
The drug NU6102 selectively targets cyclin-dependent kinase 2 (Cdk2) over Cdk4 due to interactions involving residue Asp86 and the ligand's sulfonamide group, aiding cancer treatment strategies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: